PDR Pharma will deliver presentations at PET Summer Seminar 2026 in Nagasaki.

Masato Murakami, President and Representative Director of PDR Pharma Inc. and Executive Vice President of PeptiDream Inc., will deliver a presentation titled “Beyond Existing Boundaries in Nuclear Medicine: Strategies for Translating Cutting-Edge Research into Patient Care.”

In recent years, the field of nuclear medicine has seen significant advances in diagnostic and therapeutic technologies. In his presentation, Mr. Murakami will discuss the infrastructure and systems required to bring these innovations to patients, including manufacturing and supply capabilities, as well as PDR Pharma’s initiatives to support the advancement and practical implementation of nuclear medicine.

In addition, Kanji Sugihara, Section Manager of the PET & DX Promotion Group, Product Management & Marketing Department, PDR Pharma Inc., will present on “Risk Management for the Stable Supply of Delivery PET Radiopharmaceuticals: Practical Approaches in Manufacturing, Distribution, and Administration.” His presentation will highlight initiatives and challenges related to ensuring a stable supply of PET radiopharmaceuticals.

Together, these presentations will share expertise from different professional perspectives, ranging from promoting the practical implementation of future innovations in nuclear medicine to ensuring the stable supply of PET radiopharmaceuticals that support daily clinical practice.


PDR Pharma remains committed to contributing to healthcare through academic activities and the sharing of scientific knowledge, supporting the continued advancement and practical implementation of nuclear medicine.